Skip Navigation

News & Resources


Subscribe to NHLBI Press Releases
January 29, 2016

NHLBI Announces the Recipients of 2016 Orloff Science Awards

The National Heart, Lung, and Blood Institute (NHLBI) is pleased to announce the 2016 Orloff Science Awards, which recognize outstanding achievements in science and the development of novel research tools in the previous year by investigators within NHLBI’s Division of Intramural Research.

January 26, 2016

Asthma prevention study suggests vitamin D supplementation in pregnant women might affect specific immune responses in offspring

WHAT: Providing extra vitamin D to women during pregnancy raised their vitamin D levels without changing recurrent wheezing rates in their offspring by age 3 years, National Institutes of Health-supported research found. However, in these children, who are at high risk for developing asthma, blood tests showed lower levels of specific antibodies related to allergy development, if their mothers took extra vitamin D, according to results appearing in the Journal of the American Medical Association.

Subscribe to NHLBI In The News
January 26, 2016 : JAMA

NHLBI-supported study looked at effectiveness of several popular pharmacotherapy smoking cessation therapy options. The study found three options have similar success rates.

January 11, 2016 : Time magazine

Time magazine interviewed Dr. Caroline Fox, M.D., M.P.H., a former investigator with the Framingham Heart Study of the National Heart, Lung, and Blood Institute and now a special volunteer with NHLBI, about her research linking sugar-sweetened drinks (such as sodas and sports drinks) to increased body fat.  The study, which included several NHLBI researchers, was published in the journal Circulation.

February 29, 2016 to March 1, 2016
COPD Town Hall 2016
June 2, 2016 to June 3, 2016
Natcher Conference Center Bathesda, Maryland
Sickle Cell in Focus (SCiF) is an annual two-day intensive and educational conference co-hosted by the National Heart, Lung and Blood Institutes (NHLBI) in Washington, DC and the South Thames Sickle Cell & Thalassaemia Network (STSTN) in London, UK